Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
251
Union Pacific
UNP
$174B
| $77.3M | 0.07% |
810,902
-6,403,316
| -89% | -$668M |
|
252
AMC Global Media
AMCX
$450M
| $77.2M | 0.07% |
+942,674
| New | +$73.4M |
|
253
GameStop
GME
$9.8B
| $77.1M | 0.07% |
7,174,532
+25,092
| +0.4% | +$258K |
|
254
Novartis
NVS
$302B
| $76.5M | 0.07% |
867,836
+4,899
| +0.6% | +$449K |
|
255
Avient
AVNT
$3.29B
| $76.2M | 0.07% |
1,946,561
+836,119
| +75% | +$32.7M |
|
|
XLNX
256
DELISTED
Xilinx Inc
XLNX
| $76M | 0.07% |
1,721,364
-262,774
| -13% | -$11.8M |
|
257
Ultragenyx Pharmaceutical
RARE
$2.46B
| $75.9M | 0.07% |
741,252
+5,638
| +0.8% | +$438K |
|
258
Bank OZK
OZK
$5.63B
| $75.6M | 0.07% |
1,651,414
-701,716
| -30% | -$29.8M |
|
|
SPN
259
DELISTED
Superior Energy Services, Inc.
SPN
| $74M | 0.07% |
351,699
+6,473
| +2% | +$1.51M |
|
|
KSU
260
DELISTED
Kansas City Southern
KSU
| $73.9M | 0.07% |
810,681
+60,211
| +8% | +$5.94M |
|
261
Columbia Banking Systems
COLB
$8.71B
| $73.7M | 0.07% |
2,264,821
-112,329
| -5% | -$3.43M |
|
|
PF
262
DELISTED
Pinnacle Foods, Inc.
PF
| $71.9M | 0.07% |
1,579,315
+5,339
| +0.3% | +$226K |
|
263
Rio Tinto
RIO
$152B
| $71.5M | 0.07% |
1,736,003
+11,331
| +0.7% | +$497K |
|
264
Pebblebrook Hotel Trust
PEB
$2.18B
| $70.3M | 0.06% |
1,640,206
+352,862
| +27% | +$15.4M |
|
265
The GEO Group
GEO
$4B
| $70.3M | 0.06% |
3,088,071
+104,140
| +3% | +$2.68M |
|
266
American Water Works
AWK
$27B
| $70.2M | 0.06% |
1,444,560
+3,051
| +0.2% | +$161K |
|
267
RH
RH
$3.33B
| $70.2M | 0.06% |
719,149
+15,887
| +2% | +$1.46M |
|
|
CONE
268
DELISTED
CyrusOne Inc Common Stock
CONE
| $69.9M | 0.06% |
+2,373,321
| New | +$74.1M |
|
269
Expeditors International
EXPD
$22.3B
| $69.8M | 0.06% |
+1,513,265
| New | +$71.3M |
|
270
Korn Ferry
KFY
$4.31B
| $69.4M | 0.06% |
1,996,250
-45,794
| -2% | -$1.51M |
|
|
WR
271
DELISTED
Westar Energy Inc
WR
| $69.3M | 0.06% |
2,025,376
-202,617
| -9% | -$7.41M |
|
|
QTS
272
DELISTED
QTS REALTY TRUST, INC.
QTS
| $68.9M | 0.06% |
1,890,323
+904,107
| +92% | +$33.4M |
|
273
Standard BioTools
LAB
$342M
| $68.8M | 0.06% |
2,841,248
-187,694
| -6% | -$5.92M |
|
|
CEB
274
DELISTED
CEB Inc.
CEB
| $68.6M | 0.06% |
787,620
+41,247
| +6% | +$3.51M |
|
|
RICE
275
DELISTED
Rice Energy Inc.
RICE
| $68.5M | 0.06% |
3,288,173
+44,188
| +1% | +$1M |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.